4.6 Article

Increased B Cell and Cytotoxic NK Cell Proportions and Increased T Cell Responsiveness in Blood of Natalizumab-Treated Multiple Sclerosis Patients

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

The evidence for a role of B cells in multiple sclerosis

G. Disanto et al.

NEUROLOGY (2012)

Article Multidisciplinary Sciences

Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis

Lars Bornsen et al.

PLOS ONE (2012)

Article Immunology

B cells undergo unique compartmentalized redistribution in multiple sclerosis

Juergen Haas et al.

JOURNAL OF AUTOIMMUNITY (2011)

Article Immunology

Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients

Mario Skarica et al.

JOURNAL OF NEUROIMMUNOLOGY (2011)

Review Immunology

T cells in multiple sclerosis and experimental autoimmune encephalomyelitis

J. M. Fletcher et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)

Review Immunology

Role of the innate immune system in the pathogenesis of multiple sclerosis

Roopali Gandhi et al.

JOURNAL OF NEUROIMMUNOLOGY (2010)

Review Immunology

The significance of OX40 and OX40L to T-cell biology and immune disease

Michael Croft et al.

IMMUNOLOGICAL REVIEWS (2009)

Article Multidisciplinary Sciences

Effects of Natalizumab Treatment on Foxp3+T Regulatory Cells

Max-Philipp Stenner et al.

PLOS ONE (2008)

Review Biochemistry & Molecular Biology

NK cells at the interface between innate and adaptive immunity

A. Moretta et al.

CELL DEATH AND DIFFERENTIATION (2008)

Article Clinical Neurology

Immune surveillance in multiple sclerosis patients treated with natalizumab

O Stüve et al.

ANNALS OF NEUROLOGY (2006)

Article Clinical Neurology

Natalizumab effects on immune cell responses in multiple sclerosis

M Niino et al.

ANNALS OF NEUROLOGY (2006)

Article Immunology

Phenotypic and functional characterization of human CD25+ B cells

M Brisslert et al.

IMMUNOLOGY (2006)

Article Medicine, General & Internal

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

CH Polman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Multidisciplinary Sciences

VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses

M Mittelbrunn et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)